Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Clinical trial NCT06806657 · COMPLETED

Trial details

NCT number: NCT06806657
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2025-04-28
Primary completion: 2026-06-29
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.